Gottlieb doesn't expect vaccine for kids under 5 before late March
Dr. Scott Gottlieb, the former FDA commissioner, says the FDA and Pfizer are "looking very closely at the data that's accrued to see if they can make a decision around this."
Watch CBS News
Dr. Scott Gottlieb, the former FDA commissioner, says the FDA and Pfizer are "looking very closely at the data that's accrued to see if they can make a decision around this."
The so-called "Pharma Bro" is banned for life from participating in the pharmaceutical industry.
The FDA has extended the shelf life of up to 1 million expired COVID tests that were confirmed to have been stockpiled in a Florida warehouse last week, as the state deals with spike of cases.
Florida Governor Ron DeSantis said last week that the tests weren't distributed because of "low demand."
The FDA has authorized Pfizer's COVID-19 antiviral pill for emergency use. Dr. Jodie Guest joins Elaine Quijano on CBSN's "Red & Blue" with more on the state of the pandemic.
The Food and Drug Administration has authorized booster shots for kids ages 12 to 15 and immunocompromised children ages 5 to 11, in response to the Omicron variant, which is driving a surge of COVID-19 infections in the U.S. Dr. Dyan Hes, founder of Gramercy Pediatrics, joins CBSN to discuss the latest coronavirus headlines.
The FDA authorized Pfizer's COVID-19 vaccine booster shot for children between the ages of 12 and 15. The CDC is expected to rule on the decision later this week. It comes as Omicron cases surge nationwide and millions of kids return to school following the holidays. CBS News' Wendy Gillette reports, and then Professor Jodie Guest, vice chair of the Department of Epidemiology at the Rollins School of Public Health at Emory University, joins CBSN to discuss the latest in the fight against COVID-19.
As COVID-19 cases surge across the U.S. the FDA has authorized Pfizer booster shots for children ages 12 to 15. CBS News correspondent Meg Oliver reports on how schools are proceeding with their return to class. Then Dr. Rajeev Fernando, who specializes in global infectious diseases, joins CBSN to discuss the latest on the pandemic.
Nearly half a million new COVID-19 cases were recorded in the U.S. on Wednesday. That number from the CDC is the highest single-day tally since the start of the pandemic. CBS News correspondent Nancy Chen reports from New York City. Then Dr. Payal Patel, an infectious disease physician at the University of Michigan, joined CBSN's Elise Preston to discuss the latest on the nation's health crisis.
The FDA said some of the rapid at-home tests may have "reduced sensitivity" in detecting Omicron cases, but real-world results are still coming in.
New cases of the Omicron variant are spreading rapidly in the U.S. ahead of the holidays. People are dealing with long lines at testing sites across the nation. At-home testing kits are also short in supply and pharmacies are limiting how many customers can buy. CBS News correspondent Nancy Chen reports from New York City. Then critical care physician Dr. Lakshmana Swamy joins CBSN's Debra Alfarone to discuss the latest on the pandemic.
The FDA has authorized the second antiviral pill to treat COVID-19. CBS News' Michael George reports. Then Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital at Harvard Medical School, joins CBSN to break down how the drugs work. He also explains why he thinks the CDC should implement "circuit breakers," short-term restrictions on high-risk activities to help curb the spread of the Omicron variant.
The FDA authorized the first pill to treat COVID-19. The milestone comes as U.S. cases, hospitalizations and deaths are all rising, with health officials warning of a possible tsunami of new Omicron cases that could overwhelm hospitals. Nancy Chen has the details.
Prescribing will still be limited to doctors who complete special certification.
The Food and Drug Administration banned flavored e-cigarettes, like Juul, citing their popularity among teens.
Pfizer has submitted a request for the Food and Drug Administration to provide emergency use authorization for its oral antiviral pill to help fight COVID-19 in high-risk adult patients. Dr. Payal Patel, an infectious disease physician at the University of Michigan, joins CBSN to with more on Pfizer's new pill and the pandemic.
The U.S. is experiencing a COVID-19 resurgence as new cases increased 37% nationwide this week. Some 40% of Americans remain unvaccinated. Michael George reports.
Health officials are identifying more cases of the Omicron variant in the U.S., though the Delta variant continues to be more dominant. Nikki Battiste has the latest.
New prescription eye drops could potentially replace reading glasses for people who have trouble seeing close-up. Jericka Duncan shares more.
The FDA has expanded authorization for Pfizer's COVID-19 vaccine booster for teens ages 16 and 17. Over 200 million people in the U.S. are now fully vaccinated, but the Omicron variant is raising concerns. CBS News' Bradley Blackburn reports. Then Dr. Jerry Abraham, director of vaccine programs at Kedren Health in Los Angeles, joins CBSN's Tanya Rivero from a vaccination clinic to discuss the latest.
The FDA authorized Pfizer's COVID booster shots for 16 and 17 year olds. The boosters had already been encouraged for adults. Nikki Battiste has the latest.
The FDA may soon authorize Pfizer's COVID-19 vaccine booster shot for teens 16 and 17 years old. About a quarter of Americans eligible for the booster have received it. CBS News' Laura Podesta joins "CBSN AM" to discuss the latest in the fight against the coronavirus.
Vuity, which was approved by the Food and Drug Administration in October, would potentially replace reading glasses for some of the 128 million Americans who have trouble seeing close-up.
As concerns over the new Omicron variant grow, public health experts say the Delta variant is still causing a majority of infections in the U.S. CBS News correspondent Nikki Battiste reports Omicron may cause less serious illness than other variants. Then, ER physician and Harvard Medical School professor Dr. Ali Raja joins CBSN's Elaine Quijano for the latest on COVID-19.
Dr. Scott Gotlieb, the former FDA commissioner, said last week that five of eight countries in the U.S. travel ban had turned down vaccines. He said "we do need to get capacities into these countries so it's not a recurring problem."
In an exclusive interview, California Gov. Gavin Newsom said that he will consider a presidential campaign after the 2026 midterm elections.
Thieves took less than eight minutes to steal jewels valued at $102 million last Sunday morning from Paris' famous Louvre museum.
Melissa strengthened into a major hurricane and is expected to bring "catastrophic" flash flooding and landslides to Jamaica, Haiti and the Dominican Republic.
Treasury Secretary Scott Bessent said service members will miss paychecks by Nov. 15 if the government shutdown stretches on.
The move comes even though Ontario's leader said the anti-tariff ad would be halted beginning Monday.
Former vice president Kamala Harris spoke about the possibility of a woman being in the White House one day in an interview with the BBC.
Under the fragile U.S.-brokered ceasefire, reached on Oct. 10, Hamas is expected to return all of the remains of Israeli hostages as soon as possible.
President Trump late Friday pushed for several Biden-era Justice Department officials to be prosecuted over an FBI investigation into the fallout of the 2020 election.
Jose Castro-Rivera was in a vehicle that was stopped on a Virginia highway on Thursday morning, according to Virginia State Police.